Chronic hypereosinophilia, defined as persistent elevated blood levels of eosinophils ≥1,500/μL, is associated with tissue infiltration of eosinophils and consequent organ damage by eosinophil release of toxic mediators. The current therapies for chronic hypereosinophilia have limited success, require repetitive administration, and are associated with a variety of adverse effects. As a novel approach to treat chronic hypereosinophilia, we hypothesized that adeno-associated virus (AAV)-mediated delivery of an anti-human eosinophil antibody would provide one-time therapy that would mediate persistent suppression of blood eosinophil levels.
View Article and Find Full Text PDFZh Nevrol Psikhiatr Im S S Korsakova
November 2024
Prog Neuropsychopharmacol Biol Psychiatry
October 2024
A large body of research has shown that schizophrenia patients demonstrate increased brain structural aging. Although this process may be coupled with aberrant changes in intrinsic functional architecture of the brain, they remain understudied. We hypothesized that there are brain regions whose whole-brain functional connectivity at rest is differently associated with brain structural aging in schizophrenia patients compared to healthy controls.
View Article and Find Full Text PDFMany emerging applications, such as factory automation, electric power distribution, and intelligent transportation systems, require multicast Ultra-Reliable Low-Latency Communications (mURLLC). Since 3GPP Release 17, 5G systems natively support multicast functionality, including multicast Hybrid Automatic Repeat Request and various feedback schemes. Although these features can be promising for mURLLC, the specifications and existing studies fall short in offering guidance on their efficient usage.
View Article and Find Full Text PDF